Primary prevention of dementia
Symptomatic treatments that work by enhancing neurotransmitter function have been available for several years, and are generally accepted as being modestly beneficial in about 50% of those for whom they are prescribed. Disease-modifying drugs that may prevent or retard neuronal deterioration are bei...
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Book section |
| Julkaistu: |
2004
|